Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Condition(s):Prostatic NeoplasmsLast Updated:July 14, 2014No longer available
Hide Studies Not Open or Pending
Condition(s):Prostatic NeoplasmsLast Updated:July 14, 2014No longer available
Condition(s):Hormone Refractory Prostate Cancer; Bone MetastasesLast Updated:May 27, 2016Completed
Condition(s):Prostatic NeoplasmsLast Updated:March 31, 2017Completed
Condition(s):Prostate Cancer; Castration-resistant Prostate Cancer; Castration-resistant Prostate Cancer Metastatic to BoneLast Updated:September 29, 2022Completed
Condition(s):Neoplasm Metastasis / Bone and BonesLast Updated:February 20, 2024Completed
Condition(s):Castration-Resistant Prostate Carcinoma; Metastatic Malignant Neoplasm in the Bone; Metastatic Prostate Carcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8Last Updated:November 24, 2023Recruiting
Condition(s):Hormone-Resistant Prostate Cancer; Metastatic Malignant Neoplasm in the Bone; Metastatic Prostate CarcinomaLast Updated:May 30, 2017Terminated
Condition(s):Prostate CarcinomaLast Updated:April 27, 2016Unknown status
Condition(s):Prostatic Neoplasms, Castration-ResistantLast Updated:November 2, 2021Completed
Condition(s):Bone Metastatic Castration-resistant Prostate CancerLast Updated:March 1, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.